NO962921D0 - T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling derav - Google Patents

T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling derav

Info

Publication number
NO962921D0
NO962921D0 NO962921A NO962921A NO962921D0 NO 962921 D0 NO962921 D0 NO 962921D0 NO 962921 A NO962921 A NO 962921A NO 962921 A NO962921 A NO 962921A NO 962921 D0 NO962921 D0 NO 962921D0
Authority
NO
Norway
Prior art keywords
preparation
antigen receptor
cell antigen
region proteins
proteins
Prior art date
Application number
NO962921A
Other languages
English (en)
Other versions
NO962921L (no
Inventor
Savvas C Makrides
Patrick C Kung
Original Assignee
T Cell Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc filed Critical T Cell Sciences Inc
Publication of NO962921D0 publication Critical patent/NO962921D0/no
Publication of NO962921L publication Critical patent/NO962921L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
NO962921A 1994-01-13 1996-07-11 T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling NO962921L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/181,492 US5552300A (en) 1994-01-13 1994-01-13 T cell antigen receptor V region proteins and methods of preparation thereof
PCT/US1995/000408 WO1995019435A2 (en) 1994-01-13 1995-01-12 T cell antigen receptor v region proteins and methods of preparation thereof

Publications (2)

Publication Number Publication Date
NO962921D0 true NO962921D0 (no) 1996-07-11
NO962921L NO962921L (no) 1996-09-02

Family

ID=22664497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962921A NO962921L (no) 1994-01-13 1996-07-11 T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling

Country Status (21)

Country Link
US (1) US5552300A (no)
EP (1) EP0738322A1 (no)
JP (1) JPH10501961A (no)
KR (1) KR100213396B1 (no)
AU (1) AU700661B2 (no)
BR (1) BR9506612A (no)
CA (1) CA2181171A1 (no)
CZ (1) CZ9602009A3 (no)
EE (1) EE03287B1 (no)
FI (1) FI962844L (no)
HU (1) HUT75551A (no)
IL (1) IL112316A0 (no)
LV (1) LV11630B (no)
MX (1) MX9602750A (no)
NO (1) NO962921L (no)
NZ (2) NZ279605A (no)
PL (1) PL181072B1 (no)
SG (1) SG52342A1 (no)
SK (1) SK90696A3 (no)
WO (1) WO1995019435A2 (no)
ZA (1) ZA95261B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113903A (en) * 1989-03-21 2000-09-05 The Immune Response Corporation Peptides and methods against diabetes
US7749498B2 (en) * 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en) * 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20040229282A1 (en) * 1997-03-10 2004-11-18 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) * 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US5986065A (en) * 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
WO2000061184A2 (en) 1999-04-08 2000-10-19 Glenn Gregory M Dry formulation for transcutaneous immunization
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US20030190705A1 (en) * 2001-10-29 2003-10-09 Sunol Molecular Corporation Method of humanizing immune system molecules
RU2327487C2 (ru) * 2002-08-08 2008-06-27 Бейлор Колледж Оф Медисин Выделение и идентификация т-клеток
AU2004255553B2 (en) * 2003-06-19 2009-08-20 Genentech, Inc. Compositions and methods for treating coagulation related disorders
EP1768742A4 (en) * 2004-07-06 2007-10-17 Transpharma Medical Ltd ADMINISTRATION SYSTEM FOR TRANSDERMAL IMMUNIZATION
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
US20070009542A1 (en) * 2005-07-05 2007-01-11 Galit Levin Method and device for transdermal immunization
CA2620943A1 (en) 2005-09-02 2007-03-08 Iomai Corporation Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof
CA2651328A1 (en) * 2006-05-05 2007-11-15 Opexa Therapeutics T-cell vaccine
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
CN102573883A (zh) 2009-06-12 2012-07-11 疫苗技术公司 用于促进细胞-介导的免疫应答的方法和组合物
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
ES2719495T5 (en) 2012-05-07 2025-09-10 Dartmouth College Anti-b7-h6 antibody, fusion proteins, and methods of using the same
WO2014044690A1 (en) 2012-09-18 2014-03-27 Valneva Austria Gmbh Improved vaccines

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713332A (en) * 1984-01-13 1987-12-15 The Ontario Cancer Institute T cell specific CDNA clone
DE3588219T2 (de) * 1984-03-01 2000-05-18 The Board Of Trustees Of The Leland S. Stanford Junior University, Stanford T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5024940A (en) * 1987-02-19 1991-06-18 T Cell Sciences, Inc. Nucleic acids encoding the delta chain of the T cell antigen receptor
US5260223A (en) * 1986-07-03 1993-11-09 President & Fellows Of Harvard College Methods for detection of human gamma, γ T cell receptor
US5340921A (en) * 1986-07-03 1994-08-23 T Cell Sciences, Inc. Γ, δT cell receptor and methods and detection
US5185250A (en) * 1986-07-03 1993-02-09 T Cell Sciences, Inc. Human γ, δT cell antigen receptor polypeptides and nucleic acids
EP0712928A2 (en) * 1987-06-23 1996-05-22 The Board Of Trustees Of The Leland Stanford Junior University T cell antigen receptor
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
EP0463101B2 (en) * 1989-03-21 2003-03-19 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
WO1990014068A2 (en) * 1989-05-02 1990-11-29 Irun Robert Cohen Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
US5216132A (en) * 1990-01-12 1993-06-01 Protein Design Labs, Inc. Soluble t-cell antigen receptor chimeric antigens
DE69121099T3 (de) * 1990-05-01 2001-01-25 The Board Of Trustees Of The Leland S. Stanford Junior University, Stanford Stoffgemische zur Anwendung in einem Verfahren zur Behandlung eines an multipler Sklerose leidenden Menschen
DE69124518T2 (de) * 1990-08-09 1997-05-15 National Jewish Center For Immunology And Respiratory Medicine, Denver, Col. Herstellung monoklonaler Antikörper gegen menschliches Vbeta T-Zellrezeptorelement unter Verwendung rekombinanter DNA-Vektoren
AU660306B2 (en) * 1991-02-12 1995-06-22 Roussel-Uclaf Nucleotidic sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptidic segments and diagnostic and therapeutic applications
WO1992021367A1 (en) * 1991-05-31 1992-12-10 Arthur Allen Vandenbark T cell receptor peptides as therapeutics for immune-related disease
WO1993006135A1 (en) * 1991-09-23 1993-04-01 Genentech, Inc. Diagnosing and treating autoimmune disorders
US5333487A (en) * 1991-11-15 1994-08-02 Hughes Aircraft Company Spark-excited fluorescence sensor
US5212091A (en) * 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor

Also Published As

Publication number Publication date
FI962844A7 (fi) 1996-08-29
FI962844A0 (fi) 1996-07-12
CZ9602009A3 (en) 1997-12-17
KR970700772A (ko) 1997-02-12
LV11630B (en) 1997-08-20
NZ332715A (en) 2000-06-23
EP0738322A1 (en) 1996-10-23
WO1995019435A2 (en) 1995-07-20
JPH10501961A (ja) 1998-02-24
NO962921L (no) 1996-09-02
US5552300A (en) 1996-09-03
AU1678495A (en) 1995-08-01
WO1995019435A3 (en) 1995-08-24
SK90696A3 (en) 1997-07-09
KR100213396B1 (ko) 1999-08-02
ZA95261B (en) 1995-11-14
EE03287B1 (et) 2000-08-15
CA2181171A1 (en) 1995-07-20
HUT75551A (en) 1997-05-28
IL112316A0 (en) 1995-03-30
FI962844L (fi) 1996-08-29
MX9602750A (es) 1997-05-31
AU700661B2 (en) 1999-01-14
PL181072B1 (pl) 2001-05-31
PL319374A1 (en) 1997-08-04
LV11630A (lv) 1996-12-20
NZ279605A (en) 1999-01-28
BR9506612A (pt) 1997-09-16
SG52342A1 (en) 1999-06-22
HU9601908D0 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
NO962921D0 (no) T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling derav
NO985339D0 (no) Humane B-celleantigener og beslektede reagenser
NO992779D0 (no) OB-fusjonsproteinpreparater og fremgangsmÕte for fremstilling av slike
NO980915D0 (no) Rekombinante anti-CD4-antistoff egnet for human terapi
NO996551D0 (no) Forbedrete anti-IgE-antistoffer og fremgangsmåte for forbedring av polypeptider
IT1283010B1 (it) Complesso metallocenico supportato e procedimento per la sua prepa- razione
FI904975A7 (fi) Silloitettuja vasta-aineita ja menetelmiä niiden valmistamiseksi
DK0876482T3 (da) IL-13-receptorpolypeptid
DE69508591D1 (de) Zellkultur apparat
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
PT87688A (pt) Hybrid protein c and method for its preparation
AU629121B2 (en) Test method and device to assay for total protein
GB9511752D0 (en) Protein biosensor and method for protein measurement
FI904974A7 (fi) Ristisilloitettuja vasta-aineita ja menetelmiä niiden valmistamiseksi
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
NO915017D0 (no) Monoklonale antistoffer og fremgangsmaate for deres fremstilling
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
EP0711831A3 (en) Rabbit protein G coupled receptor
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
AU9786498A (en) Human receptor proteins; related reagents and methods
NO308791B1 (no) Kompositt-fastdrivstoff og fremgangsmÕte for fremstilling derav
KR970702731A (ko) 신규한 뇌 내피 세포 단백질 및 이의 사용 방법(A novel brain endothelial cell protein and methods for its use)
DE69615850D1 (de) G-protein-gekoppelter rezeptor hnfd578
HK1023257A (en) T cell antigen receptor v region proteins and methods of preparation thereof
ITMI911634A0 (it) Sostanza proteica e procedimento per la sua preparazione

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application